Since 2009, @Whatsapp has evolved from a simple person to person instant text messaging service into a 1.3 Billion users community worldwide which were using the app anywhere from asking your friend for her recipe to companies internal notification media platform. And the penetration of the app is expected to evolve and expand to personal […]
Source: http://bit.ly/2aiajKt Fact: our most precious resource is our time. The bad news: life in the digital era can be a major time consumer with little benefits gained at the end of the day. The good news: it’s at the hand of every person to manage his/her “time leaks” to balance effectiveness with spontaneous. Here’s […]
When I first sat behind the helm of the R&D management, I had a lot on my mind and on my hands. And the clock was ticking. When the R&D team was composed of only myself, I had to be both efficient and very specific with my prioritization. A lab had to be secured, equipped, […]
A century ago, most people worked at their home proximity, most of their day was centered on labor and less on traveling. Today, with the expanding globalization culture and the availability of fast transportation means, many people commute tens and even over hundred kilometers from their home to their place of work. However, fast as […]
Almost 48 hours post the official release of the brand new iOS 7, and the world wild web is buzzing and bustling with tweets, “how to” articles, complaints and also praises for the face lift apple hinted toward some months ago. From my own experience, and from other millions of iPhone users, it is clear […]
Crystallography for beginners – part 6a – what to do when the protein doesn’t crystallize? introduction to Limited proteolysis
I will start my “Protein crystallography rescue strategies” series with a rational biochemical approach to determine the boundaries of domains.
Talking about productivity: Labguru in the academy At a small symposium held recently by Merck-Serono, Israel Makov, chairman of several Israeli biotech companies, have given a lecture about the challenges of biopharma in the coming years. He commented that the problem with current biopharma’s R&D is not the lack of knowledge, but rather the lack […]